On the contrary, KLF5 overexpression increased the sensitivity of prostate cancer cells to docetaxel (Figure S4A, S4C), suggesting that expression level of KLF5 in prostate cancer might be indicative of the cancer response to docetaxel treatment; the threshold of the KLF5 level remains to be identified though. Here, KLF5 is linked to prostate carcinoma.